Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Current Assets (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Current Assets over the past 15 years, most recently at $85.7 million for Q2 2025.

  • Quarterly results put Current Assets at $85.7 million for Q2 2025, up 5.73% from a year ago — trailing twelve months through May 2025 was $85.7 million (up 5.73% YoY), and the annual figure for FY2025 was $85.7 million, up 5.73%.
  • Current Assets for Q2 2025 was $85.7 million at Lifecore Biomedical, Inc. \De\, up from $84.2 million in the prior quarter.
  • Over the last five years, Current Assets for LFCR hit a ceiling of $158.3 million in Q1 2021 and a floor of $74.2 million in Q3 2024.
  • Median Current Assets over the past 5 years was $89.8 million (2023), compared with a mean of $104.7 million.
  • Biggest five-year swings in Current Assets: crashed 35.58% in 2023 and later grew 10.58% in 2025.
  • Lifecore Biomedical, Inc. \De\'s Current Assets stood at $150.6 million in 2021, then dropped by 20.9% to $119.1 million in 2022, then crashed by 35.58% to $76.7 million in 2023, then increased by 6.71% to $81.9 million in 2024, then increased by 4.67% to $85.7 million in 2025.
  • The last three reported values for Current Assets were $85.7 million (Q2 2025), $84.2 million (Q1 2025), and $81.9 million (Q4 2024) per Business Quant data.